Jeil Pharmaceutical presents JP-1366, a potent potassium-competitive acid blocker for treating GERD Sep. 4, 2018
An epigenetic signature in non-small cell lung cancer predicts response to anti-PD-1 therapy Sep. 4, 2018
Phase I/IIa study of SYNB-1618 in healthy volunteers establishes dose for patients with PKU Sep. 4, 2018
RSS